BioSpace News Archive

The Global Artificial Red Blood Cells market is forecasted to grow at a rate of 21.1% from USD 4.12 billion in 2019 to USD 19.11 billion in 2030.

The global clinical laboratory market size was USD 245.44 Billion in 2020 and is expected to register a steady revenue CAGR of 6.2% during the forecast period.

According to Vantage Market Research latest qualitative research the Global Oncology Market is valued at USD 283.5 Billion in 2021.

Oxurion NV a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with clinical stage assets in vascular retinal disorders, announced that it has prevailed in final proceedings before the European Patent Office in opposition to Dyax Corp.’s European patents 1 854 477 and 2 374 472.

The Series B funding was extended by 25 million euros to reach a total of 42 million euros The new funding enables a further expansion of the Temedica ecosystem, which provides holistic insights into the care realities and patient journeys of millions of patients by combining health-related data Temedica leads the way in extracting valuable insights from anonymized health data for all healthcare stakeholders in a GDPR-compliant manner MUNICH, Germany, Nov. 23, 2022 (GLOBE NEWSWIRE) --

Third-party research conducted by leading U.S. academic institutions published in a peer reviewed journal Frontiers in Immunology shows a favorable safety profile for intranasally administered foralumab and immunological activity in humans.

The Foundation for Sarcoidosis Research is pleased to announce the funding for two new pilot projects in sarcoidosis.

Bright Minds Biosciences today announced that Mark A. Smith M.D., Ph.D. will join the Company as Chief Medical Officer, effective December 1, 2022.

Nyra Medical, Inc. today announced the closing of a $20 million Series A financing.

Ryvu Therapeutics today announced third quarter 2022 financial results and provided a corporate update.